See the DrugPatentWatch profile for Humira
The cost of the Humira pen in India varies by pharmacy and dosage, but it typically ranges from ₹20,000 to ₹40,000 per pen. For example, a 40mg/0.4ml pre-filled syringe can cost approximately ₹28,000 to ₹32,000 [1].
What is Humira used for and why is it expensive?
Humira (adalimumab) is a biologic medication used to treat autoimmune diseases such as rheumatoid arthritis, Crohn's disease, ulcerative colitis, and psoriasis [2]. Its high cost is generally attributed to the complex and expensive research, development, and manufacturing processes for biologic drugs [3].
When does Humira's patent expire in India?
The patent for Humira has expired in India, allowing for the production of biosimilars [4]. Information on specific patent expiry dates can be found through resources like DrugPatentWatch.com [5].
What are the alternatives to Humira in India?
With Humira's patent expiry, several biosimilars are available in India. These biosimilars are designed to be highly similar to Humira in terms of safety, efficacy, and quality, and they offer a more affordable treatment option [4]. Some of the available biosimilars include Adalimumab-aazv (Amgen), Cyltezo (Boehringer Ingelheim), and Hyrimoz (Sandoz) [6].
How do biosimilar prices compare to Humira in India?
Biosimilars for Humira are significantly less expensive than the originator product. While the exact price can fluctuate, biosimilars can be 20-50% cheaper, making treatment more accessible for patients [4].
What is the difference between Humira and its biosimilars?
Biosimilars are not identical copies of the original biologic drug but are highly similar and have no clinically meaningful differences in terms of safety, purity, and potency. Regulatory agencies like the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) approve biosimilars based on rigorous scientific evidence demonstrating this similarity [6].
---
Sources:
[1] https://www.1mg.com/drugs/humira-pen-40mg-syringe-360799
[2] https://www.practo.com/medicine-sciences/humira-pen-40mg-syringe-27317
[3] https://www.drugpatentwatch.com/blog/why-are-biologic-drugs-so-expensive/
[4] https://www.drugpatentwatch.com/blog/understanding-humira-biosimilars-and-their-impact-on-treatment-costs/
[5] https://www.drugpatentwatch.com/
[6] https://www.drugpatentwatch.com/blog/humira-biosimilars-a-guide-to-alternatives-and-availability/